Is reactivation of HHV-6 major problem in Covid-19?
"Dursun et al. noticed an increased rate of pityriasis rosea and Kawasaki disease in patients who presented to dermatology outpatient clinics during the COVID‐19 pandemic. The authors attributed that to coronavirus triggering of HHV‐6 (i.e. endogenous viral reactivation of HHV‐6 by SARS‐CoV‐2 infection)."